tiprankstipranks
Adaptive Biotechnologies Corp (ADPT)
NASDAQ:ADPT
Holding ADPT?
Track your performance easily

Adaptive Biotechnologies (ADPT) Income Statement

856 Followers

Adaptive Biotechnologies Income Statement

Last quarter (Q3 2024), Adaptive Biotechnologies's total revenue was $46.44M, an increase of 22.46% from the same quarter last year. In Q3, Adaptive Biotechnologies's net income was $-32.07M. See Adaptive Biotechnologies’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 177.28M$ 170.28M$ 185.31M$ 154.34M$ 98.38M$ 85.07M
Cost of Revenue
$ 73.65M$ 75.55M$ 57.91M$ 49.30M$ 22.53M$ 22.27M
Gross Profit
$ 103.63M$ 94.72M$ 127.40M$ 105.04M$ 75.85M$ 62.80M
Operating Expense
$ 270.78M$ 296.33M$ 327.58M$ 314.01M$ 228.67M$ 141.19M
Operating Income
$ -199.78M$ -227.03M$ -200.19M$ -208.97M$ -152.82M$ -78.39M
Net Non Operating Interest Income Expense
$ 4.43M$ 1.73M$ -182.00K$ 1.67M$ 6.59M$ 9.79M
Other Income Expense
$ 97.27M$ -25.43M$ 99.36M$ 95.79M$ 69.82M$ 2.27M
Pretax Income
$ -144.49M$ -225.30M$ -200.37M$ -207.30M$ -146.23M$ -68.61M
Tax Provision
-----$ 2.10M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -195.24M$ -225.25M$ -200.19M$ -207.28M$ -146.23M$ -69.57M
Basic EPS
$ -1.34$ -1.56$ -1.40$ -1.48$ -1.11$ -1.01
Diluted EPS
$ -1.34$ -1.56$ -1.40$ -1.48$ -1.11$ -1.01
Basic Average Shares
$ 585.64M$ 144.38M$ 142.52M$ 140.35M$ 131.22M$ 69.17M
Diluted Average Shares
$ 585.64M$ 144.38M$ 142.52M-$ 131.22M$ 69.17M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 344.43M$ 371.88M$ 385.49M$ 363.31M$ 251.20M$ 163.46M
Net Income From Continuing And Discontinued Operation
$ -195.24M$ -225.25M$ -200.19M$ -207.28M$ -146.23M$ -68.61M
Normalized Income
$ -109.00M$ -116.61M----
Interest Expense
------
EBIT
$ -183.71M$ -211.50M$ -196.13M$ -207.30M$ -152.82M$ -68.61M
EBITDA
$ -163.50M$ -189.27M$ -175.21M$ -193.34M$ -144.34M$ -65.27M
Currency in USD

Adaptive Biotechnologies Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis